Global Biosimilars Market is estimated close to $18 Bn (2020) growing at a double-digit rate. The market growth is driven by increasing number of biosimilar approvals and growing number of biologics going off-patent.

A biosimilar is a biological product that is similar to a reference biologic in terms of potency, purity, and safety, with no clinically significant changes.